|
|
Suppliers for
JD-5037
|
Properties | CAS |
1392116-14-1 |
|
4 Registered suppliers
Molecular Formula: C27H27Cl2N5O3S
Molecular Formula: C27H27Cl2N5O3S
Description : Jd-5037 is a peripherally-restricted cannabinoid inverse agonist at CB1 receptors that can be used as an anti-obesity drug, with a 700-fold higher affinity compared to CB2 receptors. - Molecular Weight :572.5
- Purity :> 98%
Molecular Formula : C27H27Cl2N5O3S Canonical SMILES : CC(C)C(C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4 InChI : InChI=1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1 InChIKey : GTCSIQFTNPTSLO-RPWUZVMVSA-N Solubility : Soluble in DMSO. Appearance : Solid Powder Storage : Store in a cool and dry place and at 0-4 ℃ for short term (days to weeks) or -66 ℃ for long term (months to years). Synonyms : JD 5037; JD5037; (S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide
More details are to be found here
Detailed information on the suppliers of
JD-5037
|
Properties:
... more properties and specification on JD-5037
|
|
Privileged suppliers
Last update 2024-05-03
|